Silan, Coskun <br/><br/>
The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.  [electronic resource] 

 -  Molecular biology reports  Dec 2012 
 - 11017-22 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-4978 
<br/><br/><label>Standard No.: </label>10.1007/s11033-012-2004-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alleles<br/>Anticoagulants--therapeutic use<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Cytochrome P-450 CYP2C9<br/>Female<br/>Follow-Up Studies<br/>Gene Frequency--genetics<br/>Genotype<br/>Humans<br/>Male<br/>Middle Aged<br/>Mixed Function Oxygenases--genetics<br/>Polymorphism, Single Nucleotide--genetics<br/>Prevalence<br/>Turkey<br/>Vitamin K Epoxide Reductases